Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2024
Companies covered: 12
Tables & Figures: 107
Countries covered: 19
Pages: 170
Download Free PDF

Drug-eluting Balloon Catheters Market
Get a free sample of this reportGet a free sample of this report Drug-eluting Balloon Catheters Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Drug-eluting Balloon Catheters Market Size
The global drug-eluting balloon catheters market size was valued at USD 637.8 million in 2024 and is expected to exhibit growth at a CAGR of 9.9% from 2025 – 2034 period. The growing incidence of peripheral and cardiovascular diseases, a shift in preference towards non-invasive procedures, and the expanding elderly population, among other factors, can explain high market growth.
The global burden of cardiovascular diseases (CVDs), which includes coronary artery disease, strokes, and peripheral artery disease (PAD), has worsened owing to aging, sedentary lifestyle, and diabetes along with hypertension. For instance, cardiovascular diseases are the number one killer across the globe, which the CDC estimates caused around 19 million deaths in 2021. In the U.S. alone, heart disease accounted for 702,880 deaths in 2022, which is about one in every five deaths.
As a result, the demand for non-invasive solutions, such as the drug-eluting balloon (DEB) catheter, is on the rise. DEB catheters have a distinct advantage in treating arterial blockages and improving blood flow because they do not require a permanent implant. These catheters are becoming the standard for complex lesions where stents are sometimes ineffective in treating.
Moreover, the treatment of hyperplasia is aided by drug-eluting balloon catheter or drug-coated balloon catheters. The catheter is infused with an antiproliferative medicine, usually either sirolimus or paclitaxel, and the balloon aids in expanding the artery walls so that the medicine can be located. Moreover, it also provides controlled medication delivery to treat cardiovascular or peripheral problems.
Drug-eluting Balloon Catheters Market Trends
Transmitters of DEB catheter technology such as the drug, catheter, and its construction material have undergone numerous innovations leading to marked improvements in the treatment of vascular blockages in patients that suffer from coronary through or peripheral artery disease. These changes appear to be attractive to medical professionals looking for better, less invasive options, and this increases the range of applications for DEB catheters in the field.
Drug-eluting Balloon Catheters Market Analysis
Based on product, the market is classified into coronary artery disease drug-eluting balloon catheters and peripheral vascular disease drug-eluting balloon catheters. The peripheral vascular disease drug-eluting balloon catheters segment generated the highest revenue of USD 353 million in 2024.
Based on material, the drug-eluting balloon catheters market is classified into polyurethane, nylon, and other materials. The polyurethane segment accounted for USD 225.4 million in market revenue in 2024 and is anticipated to grow at a CAGR of 10.4% between the 2025 – 2034 period.
Based on end use, the drug-eluting balloon catheters market is segmented into hospitals and clinics, ambulatory surgical centers, and catheterization laboratories. The hospitals and clinics segment dominated the market in 2024 and is anticipated to reach USD 938.3 million by the end of the forecast period.
North America drug-eluting balloon catheters market accounted for USD 272.2 million in market revenue in 2024 and is anticipated to grow at a CAGR of 8.4% between the 2025 – 2034 period.
France drug-eluting balloon catheters market is projected to grow remarkably in the coming years.
Japan holds a dominant position in the Asia Pacific drug-eluting balloon catheters market.
Drug-eluting Balloon Catheters Market Share
The market has always been active, and it is becoming even more so with the presence of large multinationals such as B. Braun and Becton, Dickinson and Company and Boston Scientific Corporation investing heavily in innovation and expanding their product portfolios. Important progress is achieved also by regional companies and new entrants especially from Asia Pacific. Ongoing product development is driven by technological innovations such as improvements in vaccine efficacy, safety, and storage and distribution methods. As companies attempt to increase market share and improve their technological base, strategic alliances, mergers, and acquisitions become ordinary.
Drug-eluting Balloon Catheters Market Companies
Prominent players operating in the drug-eluting balloon catheters industry include:
USPs for Top Players:
Drug-eluting Balloon Catheters Industry News:
The drug-eluting balloon catheters market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Material
Market, By End Use
The above information is provided for the following regions and countries: